[OFER-TRABEC] NAC: Postdoctoral candidates for a Sara Borrell fellows

===
Boletín semanal de ofertas de empleo publico
http://administracion.gob.es/pag_Home/empleoBecas/empleo/boletinEmpleoPublico.html
===

---Procedencia:
Institución:IDIBELL
Contacto correo-e:mapujana@iconcologia.net
---
Postdoctoral candidates for a Sara Borrell fellowship application in Cancer Research (IDIBELL, Barcelona)

We seek for:
- An excellent skilled postdoc with a strong publication record in cancer biology.
- The postoc should apply to the Sara Borrell Fellowship program of the Ministry of Health ISCIII. Applicants must have first-authored publications in respected journals.
- The candidates should be self-motivated and independent, and have strong training in cell or molecular biology, mathematics, statistics or physics.

The research group is situated within the Catalan Institute of Oncology (Bellvitge Institute for Biomedical Research, IDIBELL). The Institute offers strong interactive environment and various excellent opportunities for collaborative research exists within the institute and the surrounding Hospital area.

Interested applicants are encouraged to apply with an email containing your curriculum vitae and names and contact information of two referees to Miquel Àngel Pujana (email: mapujana@iconcologia.net).
www.cancersystemsbiology.cat

Deadline for applications is 15 April 2016.


----------------
Información complementaria de la oferta:
Publications by the group:
Aguilar et al. (2014). VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014 May 28;16(3):R53.
Bonifaci et al. (2014). Integrating gene expression and epidemiological data for the discovery of genetic interactions associated with cancer risk. Carcinogenesis. Jan 2., 2014.
Maxwell et al. (2011). Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. PLoS Biology Nov;9(11):e1001199.
Aguilar et al. (2010). Biological reprogramming in acquired resistance to endocrine treatment of breast cancer. Oncogene 29(45):6071-83.